Masaharu Matsumura
Nihon University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Masaharu Matsumura.
Thrombosis Research | 2012
Hiroshi Yagasaki; Maiko Kato; Katsuyoshi Shimozawa; Maiko Hirai; Eri Nishikawa; Hirotsugu Okuma; Wakako Ishii; Yuki Imai; Masaharu Matsumura; Ryuta Yonezawa; Kayo Yoshikawa; Hiroyuki Shichino; Motoaki Chin; Hideo Mugishima
INTRODUCTION Recombinant thrombomodulin (rTM), which degrades factors Va and VIIIa by activating protein C, has been developed as a new drug for treating disseminated intravascular coagulation (DIC). MATERIALS AND METHODS Since July 2009, we have treated 25 children with DIC using rTM (380 U/kg/day, or 130 U/kg/day for newborns) as a first-line therapy. Median duration of rTM administration was 5 consecutive days (range, 2-13 days). We employed DIC criteria of the Japan Welfare and Health Ministry. The first day on which rTM treatment was given was defined as day 1. RESULTS Median patients age was 3 years. Underlying diseases were hematological disorders (n=13) and severe infection (n=12). Overall, 20 of the 25 patients had recovered from DIC by day 7 and 22 of the 25 patients remained alive at day 28. Median Pediatric Logistic Organ Dysfunction score improved from 11 on day 1 to 2 on day 7 (p=0.009). Laboratory data (median) on day 7 (prothrombin time (PT) ratio, 1.15; fibrin and fibrinogen degradation products (FDP), 9.6 mg/l; D-dimer, 1.6 mg/l FEU; antithrombin, 112%; protein C, 105%) were significantly improved compared to results on day 1 (PT ratio, 1.39; FDP, 21.6 mg/l; D-dimer, 6.4 mg/l FEU; antithrombin, 86%; protein C, 54%). Whereas, 5 patients failed to respond and serious bleeding events were observed in 2 newborns. CONCLUSION The efficacy of rTM cannot be assessed from the present dataset, due to several limitations such as the small heterogenous patient cohort, and the lack of age- and disease-matched controls. Nevertheless, this case-series remains important in terms of enabling further prospective control studies to evaluate the efficacy of rTM in children.
International Journal of Cardiology | 2009
Hiroshi Kanamaru; Kensuke Karasawa; Rie Ichikawa; Masaharu Matsumura; Michio Miyashita; Kazuo Taniguchi; Mamoru Ayusawa; Naokata Sumitomo; Hideo Mugishima
Bland-White-Garland syndrome (BWG) is a rare disorder that includes abnormalities of the coronary arteries that cause severe myocardial ischemia or infarction in infancy. In this case report, we describe an infant with BWG evaluated by dual single photon emission computed tomography using thallium-201 and I-123 beta-methyl-p-iodophenyl-pentadecanoic acid before and after surgery.
Pediatrics International | 2015
Hirofumi Watanabe; Mamoru Ayusawa; Masataka Kato; Ami Chou; Akiko Komori; Yuriko Abe; Masaharu Matsumura; Hiroshi Kamiyama; Hiroyuki Izumi; Shori Takahashi
We report the case of a 9‐year‐old girl with Down syndrome (DS) diagnosed with idiopathic pulmonary hemosiderosis (IPH). Although acute pneumonia complicated by hemolytic anemia was suspected, IPH was finally diagnosed on bronchoscopy. Treatment with prednisolone achieved good clinical response. An association between IPH and DS was not able to be identified, but immunological issues in DS may contribute to the onset of IPH. Recurrent and intractable respiratory symptoms with marked infiltrative shadows in the bilateral lungs and complicated by severe anemia in patients with DS should suggest IPH.
Heart and Vessels | 2014
Yuriko Abe; Naokata Sumitomo; Hiromi Okuma; Takahiro Nakamura; Junji Fukuhara; Rie Ichikawa; Masaharu Matsumura; Michio Miyashita; Hiroshi Kamiyama; Mamoru Ayusawa; Mamie Watanabe; Kunitaka Joo; Naomasa Makita; Minoru Horie
We present a case of a 9-month-old girl in whom malignant polymorphic ventricular tachycardia (VT) was successfully controlled by radiofrequency catheter ablation under guidance with a three-dimensional mapping system. The VTs originated from the left ventricular lateral wall, left ventricular anterior wall, and left ventricular apex. At least six types of VTs were documented during the electrophysiology study. All VTs were successfully controlled after two sessions of radiofrequency catheter ablation, and she was discharged from our hospital on propranolol, mexiletine, flecainide, and aprindine.
Journal of Cardiovascular Magnetic Resonance | 2013
Satoshi Kunimoto; Kensuke Yamamoto; Rie Ichikawa; Junji Fukuhara; Masaharu Matsumura; Naokata Sumitomo; Yasuo Okumura; Ichiro Watanabe
Background Radio-frequency catheter ablation (RFCA) in children is difficult because the size of heart chamber change with age and the catheter made for adults is not appropriate for a child. Three-dimensional (3D) images for electroanatomic mapping (EAM) have been used to create from images of multi-detector computed tomography (MDCT) which need to perform entailed by contrast medium injection and radiation exposure. This study sought to evaluate the usability of 3D Cardiac Magnetic Resonance Image (CMR) in pediatrics cases.
Circulation | 2007
Naokata Sumitomo; Harumizu Sakurada; Kazuo Taniguchi; Masaharu Matsumura; Osamu Abe; Michio Miyashita; Hiroshi Kanamaru; Kensuke Karasawa; Mamoru Ayusawa; Seiji Fukamizu; Iori Nagaoka; Minoru Horie; Kensuke Harada; Masayasu Hiraoka
Circulation | 2011
Rie Ichikawa; Naokata Sumitomo; Akiko Komori; Yuriko Abe; Takahiro Nakamura; Junji Fukuhara; Masaharu Matsumura; Michio Miyashita; Hiroshi Kanamaru; Mamoru Ayusawa; Hideo Mugishima
Circulation | 2011
Junji Fukuhara; Naokata Sumitomo; Takahiro Nakamura; Rie Ichikawa; Masaharu Matsumura; Osamu Abe; Michio Miyashita; Kazuo Taniguchi; Hiroshi Kanamaru; Mamoru Ayusawa; Kensuke Karasawa; Hideo Mugishima
Journal of Nihon University Medical Association | 2013
Masaharu Matsumura; Taro Matsumoto; Koichiro Kano; Hideo Mugishima
Journal of Arrhythmia | 2011
Yuriko Abe; Naokata Sumitomo; Junji Fukuhara; Rie Ichikawa; Masaharu Matsumura; Michio Miyashita; Hiroshi Kanamaru; Mamoru Ayusawa; Hideo Mugishima; Mamie Watanabe; Kunitaka Joo